SCHEMBL4853687

SCHEMBL4853687

C=CC(C)(C)c1ccc(OCCN(C)C)c(C(=O)C=Cc2ccc(OC3CCCCO3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.38
BCHE P06276 4/20 0.37
ACHE P22303 4/20 0.37
MAOB P27338 2/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
FLT3 P36888 1/20 0.35
CYSLTR2 Q9NS75 1/20 0.34
CYSLTR1 Q9Y271 2/20 0.34
MAOA P21397 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852534 1.00 PTPN1 (0.38) PTPN1BCHEACHEMAOBABCG2
SCHEMBL4852542 0.87 PTPN1 (0.50) PTPN1BCHEACHEABCG2
SCHEMBL4854283 0.82 BCHE (0.45) BCHEACHEMAOBMAOA
SCHEMBL6908220 0.74 ABCG2 (0.65) ABCG2FLT3
SCHEMBL4849756 0.72 KDM4E (0.51) BCHEACHEMAOBMAOA
SCHEMBL4849818 0.72 KDM4E (0.51) BCHEACHEMAOBMAOA
SCHEMBL21527715 0.72 ABCG2 (0.60) PTPN1MAOBABCG2MAOA
SCHEMBL21527716 0.72 ABCG2 (0.60) PTPN1MAOBABCG2MAOA
SCHEMBL4848189 0.71 ADRB2 (0.37) PTPN1
SCHEMBL21527714 0.71 ABCG2 (0.65) MAOBABCG2FLT3MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP claimed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed